Scholarlink

Background <p><i>Mycoplasma pneumoniae</i> (<i>M. pneumoniae</i>)-associated community-acquired pneumonia (CAP) is common in children. Cytomegalovirus (CMV) is frequently detected in respiratory samples in this patient population. We aimed to explore the clinical implications of positive CMV DNA in bronchoalveolar lavage fluid (BALF) from immunocompetent children with <i>M. pneumoniae</i>-associated CAP.</p> Methods <p>A retrospective cohort study was conducted for <i>M. pneumoniae</i>-associated CAP children under two years old with CMV DNA test in BALF between January 1, 2022 and September 30, 2025. These children were assigned to the BALF CMV DNA positive group or negative group. Then, the inter-group characteristics were compared.</p> Results <p>Among the 66 children, 28 and 38 children were assigned to the CMV DNA positive and negative groups, respectively. Children in the BALF CMV DNA positive group were more likely to experience duration of fever ≥ 3 days, had a higher incidence of severe <i>M. pneumoniae</i>-associated CAP at admission, and required longer hospital stays. However, these children had a lower incidence of wheezing, when compared to children in the BALF CMV DNA negative group. Furthermore, virus co-infection was common in the BALF CMV DNA negative group, when compared to the BALF CMV DNA positive group (60.5% vs. 35.7%, <i>p</i> = 0.046). The multivariable logistic regression analysis revealed that severe <i>M. pneumoniae</i>-associated CAP at admission was significantly associated with positive BALF CMV DNA (odds ratio [OR]: 22.403, 95% confidence interval [CI]: 5.429–89.503, <i>p</i> &lt; 0.001), and co-infection was significantly associated with wheezing (OR: 6.024, 95% CI: 2.037–17.857, <i>p</i> = 0.001). All children fully recovered after intravenous azithromycin administration.</p> Conclusions <p>Both BALF CMV DNA positive and negative children with <i>M. pneumoniae</i>-associated CAP can reach full recovery after azithromycin treatment. However, the former group had stronger inflammations and required longer hospital stays, while the latter group were more likely to have virus co-infection.</p> Clinical trial number <p>Not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical significance of cytomegalovirus detection in young children with Mycoplasma pneumoniae-associated community-acquired pneumonia: a retrospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月30日

查看全文
  • Xiyang Guo,
  • Zhiao Du,
  • Ting Wang,
  • Heting Dong,
  • Jiawei Chen,
  • Peng Mo,
  • Zhengrong Chen,
  • Yuqing Wang,
  • Huiming Sun

摘要

Background

Mycoplasma pneumoniae (M. pneumoniae)-associated community-acquired pneumonia (CAP) is common in children. Cytomegalovirus (CMV) is frequently detected in respiratory samples in this patient population. We aimed to explore the clinical implications of positive CMV DNA in bronchoalveolar lavage fluid (BALF) from immunocompetent children with M. pneumoniae-associated CAP.

Methods

A retrospective cohort study was conducted for M. pneumoniae-associated CAP children under two years old with CMV DNA test in BALF between January 1, 2022 and September 30, 2025. These children were assigned to the BALF CMV DNA positive group or negative group. Then, the inter-group characteristics were compared.

Results

Among the 66 children, 28 and 38 children were assigned to the CMV DNA positive and negative groups, respectively. Children in the BALF CMV DNA positive group were more likely to experience duration of fever ≥ 3 days, had a higher incidence of severe M. pneumoniae-associated CAP at admission, and required longer hospital stays. However, these children had a lower incidence of wheezing, when compared to children in the BALF CMV DNA negative group. Furthermore, virus co-infection was common in the BALF CMV DNA negative group, when compared to the BALF CMV DNA positive group (60.5% vs. 35.7%, p = 0.046). The multivariable logistic regression analysis revealed that severe M. pneumoniae-associated CAP at admission was significantly associated with positive BALF CMV DNA (odds ratio [OR]: 22.403, 95% confidence interval [CI]: 5.429–89.503, p < 0.001), and co-infection was significantly associated with wheezing (OR: 6.024, 95% CI: 2.037–17.857, p = 0.001). All children fully recovered after intravenous azithromycin administration.

Conclusions

Both BALF CMV DNA positive and negative children with M. pneumoniae-associated CAP can reach full recovery after azithromycin treatment. However, the former group had stronger inflammations and required longer hospital stays, while the latter group were more likely to have virus co-infection.

Clinical trial number

Not applicable.